/Companies

Synthase Biotech Ltd

2 known investors

Find your way into Synthase Biotech Ltd

Sign up to see every warm intro you have to Synthase Biotech Ltd

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Synthase Biotech Ltd team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Early-stage company commercialising the Aloxsyn® enzyme technology that prevents and repairs lipid oxidation damage in cell membranes, initially applied to livestock fertility (AI and IVF) with broader potential in human fertility and food/beverage shelf life.

Investors · 2

Frequently asked questions

What does Synthase Biotech Ltd do?
Early-stage company commercialising the Aloxsyn® enzyme technology that prevents and repairs lipid oxidation damage in cell membranes, initially applied to livestock fertility (AI and IVF) with broader potential in human fertility and food/beverage shelf life.
Who are Synthase Biotech Ltd's investors?
Synthase Biotech Ltd's investors include Matū, NZ Growth Capital Partners.